American Association for Cancer Research

Decades of scientific advances have transformed outcomes for many children with cancer. The five-year survival rate for pediatric cancer increased from 63% in the 1970s to 87% in 2015-2021, with rates exceeding 90% for certain types. Continued growth will require sustained investment in pediatric cancer research and collaboration. Margaret Guedes and Annie A. Huang, PhD, at the AACR Special Conference on Pediatric Cancer where a new grant was announced for pediatric leukemia research.

Two decades ago, Robert H. Vonderheide, MD, DPhil, FAACR, director of the Abramson Cancer Center of the University of Pennsylvania and AACR President-Elect was gifted a faux orchid for his office because a colleague noticed he couldn’t keep a real plant alive. Fortunately, for what Vonderheide lacked in horticulture, he made up through his accomplishments as a cancer immunologist and mentor.

Thanks to advances in prevention, screening, and treatment, cancer mortality has declined over the past decades. Uterine cancer, however, stands as a notable exception, with incidence and mortality on the rise. Now the leading cause of death among gynecologic cancers in the United States according to National Cancer Institute estimates, uterine cancer is projected to claim more lives than ovarian cancer in 2026.

WASHINGTON, D.C. – As the founding organizer and lead sponsor of the 14th annual Rally for Medical Research Hill Day taking place today, September 17, the American Association for Cancer Research (AACR) is joining a nationwide coalition of more than 400 organizations to advocate for a robust funding increase for the National Institutes of Health (NIH) in fiscal year (FY) 2027 to safeguard the future of lifesaving medical research.

With school back in session, take a moment to educate yourself on some of the latest advances in cancer research published in the ten peer-reviewed journals of the American Association for Cancer Research (AACR). This month’s Editors’ Picks include insights into cancer evolution in leukemia, a strategy for overcoming drug resistance, the impacts of the COVID-19 pandemic on cancer care, an investigational treatment for triple-negative breast cancer, and more.

PHILADELPHIA – Today, the American Association for Cancer Research (AACR) released the 16th edition of its annual Cancer Progress Report. This comprehensive report provides current data on cancer incidence, mortality, and survivorship.

For Tsedey Tsegaye, the Margaret Foti Scholarship was more than a way to fund her education. It was a lifeline: a path out of war-torn Ethiopia and a chance to reclaim her dreams and the version of herself that the war had stolen. In many ways, she says, the scholarship saved her life.

Skip to Content Home > About the AACR > Newsroom > News Release > Response to Neoadjuvant Immunochemotherapy May Allow for Surgical De-escalation in Head and Neck Cancers PHILADELPHIA – Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors responded to neoadjuvant immunochemotherapy (ICT) and who underwent less extensive surgery had high disease-free survival and organ preservation rates, according to a study published in Clinical Cancer Research, a journal...

A quarter century has now passed since September 11, 2001, a date that continues to live in infamy—an infamy that, increasingly, is remembered in the same abstract manner as other episodes in the sprawling tide of history. But the effects of the 9/11 attacks still define lives, especially those of the first responders whose health continues to be impacted by the exposures to toxins and irritants they incurred at ground zero.

The following declaration is unlikely to make headlines, but the fact bears repeating: Smoking cigarettes causes cancer. This wisdom has been well-absorbed. Cigarette smoking, especially youth smoking, remains at an all-time low in the United States. If there are any increases in youth smoking, they have yet to appear in the federal data. Message received, right? Yes—mostly.